Looking and Listening to Light from Liposome Nanostructures for Cancer Theranostics
Chair Prof. Dr. Jan Mollenhauer, NanoCAN, University of Southern Denmark, (DK) Speaker: Prof. Dr. Kostas Kostarelos, FRSM, FIoN, FRSA, Chair of Nanomedicine,...
By: TAUVOD
Read the original:
Looking and Listening to Light from Liposome Nanostructures for Cancer Theranostics - Video
image:Left: Primary tumor or overt metastasisCenter: Center: Pre-metastatic nicheRight: Post-surgical wound view more
Credit: 2021 Innovation Center of NanoMedicine
Summary:Matrix metalloproteinases (MMPs) is an enzyme required for cancer cells to metastasize/invade, and cancer cells with higher MMP activity have higher metastasis ability and progress quickly.In this study, we created polymersomes (smart nanomachines) that act specifically in tissues that overproduce MMPs, prevent cancer metastasis, and developed a method to remove residual tumor tissue that could not be visually confirmed after surgery.We simultaneously loaded the cell division inhibitor colchicine and the MMP inhibitor marimastat into MMPs-responsive polymersomes as an enzymatically transformable nanomachine designed to achieve transformation following dePEGylation by cleavage of the inserted substrate peptide by MMPs. The effect on malignant tumors with high MMPs activity was evaluated.During transformation, nanomachines with exposed guanidine residues easily penetrate into cells, and at the same time, by releasing the contained drugs, it exerts an anti-cancer effect.Evaluating drug uptake using HT1080 cells derived from human fibrosarcoma that overproduce MMPs, studying pharmacokinetic and nano-bio interaction using a confocal laser scanning biomicroscope and evaluating metastasis inhibitory effect using triple-negative breast cancer transplantation model, the results were published in Advanced Materials (IF = 30.849 in 2021).
J. Li, Z. Ge, K. Toh, X. Liu, A. Dirisala, W. Ke, P. Wen, H. Zhou, Z. Wang, S. Xiao, J. F. R. Van Guyse, T. A Tockary, J. Xie, D. G.-Carter, H. Kinoh, S. Uchida, Y. Anraku, and K. Kataoka, Advanced Materials, 2021.DOI: 10.1002/adma.202105254URL: https://onlinelibrary.wiley.com/doi/10.1002/adma.202105254
October 8, 2021, Kawasaki (Japan) and Hefei (China): The Innovation Center of NanoMedicine, Kawasaki Institute of Industrial Promotion (Director General: Kazunori KATAOKA, location: Kawasaki-ku, Kawasaki-City; abbreviated name: iCONM), in collaboration with the Chinese Academy of Science (CAS) Key Laboratory of Soft Matter Chemistry (USTC: University of Science and Technology), has created nanomachines that detect MMPs (matrix metalloproteinases), a principal enzyme for cancer cells to invade normal tissue, and deliver anticancer drugs according to an announcement in the journal Advanced Materials (IF = 30.849). As it can target highly invasive cancer cells, it is expected to inhibit cancer metastasis and recurrence.
Cancer is known as a malignant tumor due to its characteristics of metastasis, recurrence, and invasion, and preventing them is one of the most effective ways for treatment. When cancer cells metastasize, they need to pass through (invade) normal tissues, and in doing so, they use extracellular proteases (proteolytic enzymes) called MMPs to destroy the fibrous tissue (matrix) that binds cells to cells and tissues to tissues. In this study, we focused on tissues and cells that overproduce MMPs and incorporated the cell division inhibitor colchicine and the MMP inhibitor marimastat into MMPs-responsive polymersomes as an enzymatically transformable nanomachine (ETN). The ETN was designed to possess an amino acid sequence that serves as a specific cleavage site for MMPs and thus be capable of releasing the PEG and exposing the guanidine residue after cleavage. In the drug uptake experiment using human fibrosarcoma-derived HT1080 cells, we found that the fluorescently labeled ETN (Cy5-ETN) had a 10-fold higher uptake than that of an inert vehicle without enzymatic transformation behavior. High cellular uptake enabled strong cytotoxicity of colchicine-loaded ETN with IC50 = 0.015 M compared to the inert vehicle with IC50 = 0.402 M.Observation of mice treated with ETN using confocal laser scanning biomicroscopy showed no leakage out of blood vessels in the auricle and normal liver; strikingly, the nanomachines were found to extensively invade the tumor-associated tissues in breast cancer with high MMPs expression.
In pharmacological experiments with mice, we evaluated the antitumor effect for primary and secondary tumor using MDA-MB-231/LM2 (human) and 4T1 (mice) triple-negative breast cancer models. As a result, the ETN simultaneously encapsulating with colchicine and marimastat had a strong antitumor effect and prolonged survival in both triple-negative breast cancer models. In addition, on the basis of metastasis-prone phenotype of this model after orthotopic transplantation, the ETN was also confirmed to efficiently inhibit lung metastasis because of residual tumor targetability. Our results prove an applicable technology for not only to cancers but also to other diseases with high expression of MMPs.
Kawasaki Institute of Industrial Promotion (KIIP)Kawasaki Institute of Industrial Promotion was established in 1988 funded 100% from Kawasaki City for the purpose of coping with the hollowing out of industry and changes in the demand structure. In order to realize a higher level of market development, transforming R&D type companies, training technological capabilities to support it, human resources development, understanding market needs, etc., by utilizing the functions of the Kawasaki, KIIP has been contributing to revitalize the local economy by promoting exchanges of local industry information, advancing technology and corporate exchanges with establishment of a R&D institutions, developing creative human resources through workshops and promoting businesses such as expanding sales channels through exhibition business.https://www.kawasaki-net.ne.jp/
Innovation Center of NanoMedicine (iCONM)Innovation Center of NanoMedicine (iCONM) started its operation in April 2015 as a core research center in life science field at King SkyFront on the request of Kawasaki city that KIIP utilized national policies as a business operator and proposer. It is a unique research center that the world has ever seen which is designed for the purpose of promoting open innovation through industry-academia-government/medical-engineering collaboration, prepared with state-of-the-art facilities and experimental equipment, that enables comprehensive research and development from organic synthesis / microfabrication to preclinical testing.iCONM: https://iconm.kawasaki-net.ne.jp/en/index.html
University of Science and Technology of China (USTC)The University of Science and Technology of China (USTC) is a public research university of China with scientific and technological research as core strength, under the leadership of the Chinese Academy of Sciences (CAS). Its foundation in 1958 was hailed as "A Major Event in the History of Chinese Education and Science.". USTC has three National Research Institutions and 6 State Key Laboratories and 18 Key Laboratories of the CAS. USTC actively promotes cooperation and exchange with around 100 universities and research institutions in more than 30 nations and regions. In recent years, USTC is ranked in the world's top 100 universities in the most-widely read university rankings.USTC: http://en.ustc.edu.cn
October 8, 2021
Advanced Materials
Enzymatically Transformable Polymersome-Based Nanotherapeutics to Eliminate Minimal Relapsable Cancer
7-Oct-2021
Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.
Read the original post:
Creating smart nanomachines to detect highly invasive cancer after surgery and prevent recurrence - EurekAlert
Nanomaterials are a significant and diversified class of materials with use in nearly every major economic sector, including production, health, and power. Every year, the use of synthesized nanoparticles in consumer items grows rapidly.
Image Credit:LuckyStep/Shutterstock.com
Within industrial production or research laboratories environment, thermo-analytical analyses are frequently used to provide precise data on nanomaterials, such as insinuating material composition and nanoparticle purity, as well as crystallinityand formation kinetics of nanoparticles.
Before implementing nanoparticles in anyprocess,the most crucial factor in evaluating isnanoparticle purity. Thermal analysis is an efficient method for assessing the purity of nanoparticles by decomposing the material with little specimen preparation.
Nanoparticle modifications, such as the insertion of surface properties, can also be evaluated between chemical changes. Identifying the chemical constituents of nanoparticles, particularly during production and fabrication, is a key aspect in assessing nanomaterial purity.
Some nanomaterials are synthesized using solution-based techniques, in which components combine to form the product, with nanoparticles developing as the substance crystallizes. Chemical vapor deposition (CVD) and physical vapor deposition (PVD) are used to make other nanoparticles.
Some nanoparticle production processes rely on the trapping of other molecules, resulting in nanoparticle productionwith undetermined contents. In these circumstances, knowing how much of each constituent is present is critical for establishing nanoparticle purity.
TGA can be utilizedto determine the final concentration of nanoparticles by examining their constituents (mass percentage of each component). Centrifugation or other strategies must be used to separate the nanoparticle substances from the encapsulating solvent.
Increasing the temperatureand comparing the combustion thermal transitions to pure components can reveal its chemical composition.Information about nanoparticle morphology and size may be required to determine total mass loss per nanoparticle using thermogravimetric analysis (TGA) or differential scanning calorimetry (DSC). DSC and TGA can be used to determine the purity of synthesized nanomaterials by comparing them to standards.
TGA is one of the fastest ways for determining the relative amounts of pure carbon, bonded hydrocarbons, structured carbon, and heterogeneous catalyst particles in a carbon nanotube (CNT) sample material.
Amorphous carbons oxidizeat around 200 C., single-wall CNTsat 400 C., multi-wall CNTs at 600 C., and anything above 650 degrees Celsius is due to a solid catalyst and its oxidants.
TGA can offer a measurement of purity for CNT particles by calculating the amount of the material that degrades at a suitable temperature range. TGA is also useful for evaluating the thermal behaviorof carbon nanotubes in an oxidizing atmosphere.
Thermal analysis offers a variety of benefits that make it a useful complement to other nanomaterials analytical techniques. Nanoparticle sample preparation (i.e., specimen quantity) is typically minimal, and no additional changes such as luminous labeling are required to implement the examination. TGA, DSC, and other colorimetry methods are among the techniques that can be used.
Thermal analysis can be used in industrial settings to investigate the purityof nanoparticles because industrial equipment is accessible and interpretation of the data is often simple. The purityof nanoparticles may be determined rapidly in the lab with little specimen preparation, and the findings can be matched to other analytical techniques for extra assurance.
Thermal techniques can also be used to detect activities that might alter nanoparticle purity, such as when the nanoparticle is subjected to liquid or a biological environment. As more complex synthesis procedures are used, the dynamics of nanoparticle excitons are becoming increasingly essential. Nanoparticle systems, such as nanostructured materials, can have their composition and reaction kinetics compared to their nanoparticle content and purity.
One technology that is making development in the implementation of nanomaterial products is nano-calorimetry. Nano-calorimetry is a sensor-basedsystem able to measure samples of nanoliters in volume or milligrams to nanograms in weight with a precision of less than five nW for measuring transition temperature.
Analyses of as-produced specimens and their relationship with the environment, as well as contacts between nanomaterials and organisms, are achievable because of the small sample volumes, which is essential in the field of nanomedicine.
TGA has also made significant progress in terms of delivering nanoscale breakdown information. Microscale TGAcanbe used to detect CNT deterioration, as well as quantitative investigations of coating on gold and quartz nanoparticles. Thedata obtainedcan be linked to traditional TGA or other analytical results.
For the investigation of nanomaterials and applications incorporating nanoparticles, thermal analysis approaches are now extensively used. To make thermal analysis techniques more suited for nanoparticle systems, upgrades should be considered. It is critical to be able to minimizesample sizes, increase susceptibility, and evaluate nanomaterial-matrix interaction. Due to recent improvements in thermos-analytical techniques, nanoparticle evaluation on small scales is now attainable.
Thermal Analysis; A Useful Tool for Nanocomposite Analysis
Mansfield, E. (2015). Recent advances in thermal analysis of nanoparticles: Methods, models and kinetics.Modeling, Characterization, and Production of Nanomaterials, 167-178. https://doi.org/10.1016/B978-1-78242-228-0.00006-5
Mansfield, E., Tyner, K. M., Poling, C. M., & Blacklock, J. L. (2014). Determination of nanoparticle surface coatings and nanoparticle purity using microscale thermogravimetric analysis.Analytical chemistry,86(3), 1478-1484. https://doi.org/10.1021/ac402888v
Mansfield, E., Kar, A., & Hooker, S. A. (2010). Applications of TGA in quality control of SWCNTs.Analytical and bioanalytical chemistry,396(3), 1071-1077. https://10.1007/s00216-009-3319-2
Disclaimer: The views expressed here are those of the author expressed in their private capacity and do not necessarily represent the views of AZoM.com Limited T/A AZoNetwork the owner and operator of this website. This disclaimer forms part of the Terms and conditions of use of this website.
See original here:
Establishing Nanoparticle Purity with Thermal Analysis - AZoNano
A new study by researchers atThe Ohio State University Comprehensive Cancer Center Arthur G. James Cancer Hospital and Richard J. Solove Research Institute(OSUCCC James) shows that RNA nanoparticles have elastic and rubbery properties that help explain why these particles target tumors so efficiently and why they possess lower toxicity in animal studies.RNA nanoparticles show great promise for the targeted delivery of anticancer drugs. Understanding their structure and behavior is essential for their possible future use.
This study, published in the journalACS Nano, reveals that RNA nanoparticles have elastic and rubbery properties that enable the molecules to stretch and return to their normal shape. Researchers say that these properties could help the particles target tumors by enabling them to slip through the poorly formed walls of tumor blood vessels and enter a tumor mass.
The researchers further proved that the same rubbery properties enable the RNA nanoparticle to slip through the kidneyfiltersto excrete into the urine half an hour after systemic injection, thereby eliminating them from the body relatively quickly. That, in turn, could reduce retention of the anticancer agent in vital organs, lowering an agents toxicity.
We show that RNA nanoparticles have a flexibility that allows for the assembly of molecular structures that have stretchable angles, says study leader and corresponding authorPeixuan Guo, PhD, professor in the College of Pharmacy and theSylvan G. Frank Endowed Chair in Pharmaceutics and Drug Delivery. Guo also is in the OSUCCC JamesTranslational Therapeutics Research Program.
These findings demonstrate the rubbery properties of RNA nanoparticles and why these molecules hold great promise for industrial and biomedical applications, especially as carriers for targeted delivery of anticancer drugs, says Guo, who directs Ohio StatesCenter for RNA Nanobiotechnology and Nanomedicine.
For this study, Guo and his colleagues tested the elasticity of nucleic acid polymers by stretching and relaxing individual RNA nanoparticle, while subjecting RNA nanoparticles to elasticity studies using dual-beam optical tweezers built in Guo lab. Finally, they used animal models to study the biodistribution, excretion and retention of RNA nanoparticles. This included measuring excretion of the particles in urine, along with the study on the effect of their shape and size.
Key findings include:
RNA nanoparticles are stretchable and shrinkable, like rubber, even after repeated extension and relaxation with multiple repeats by optical tweezers.
In animal models, RNA nanoparticles show stronger cancer targeting and lower accumulation in healthy organs when compared to gold and iron nanoparticles of similar size.
Also in animal models, within half hour after systemic injection, RNA nanoparticles that were 5, 10 and 20 nm in size were filtered by the kidneys and retained their original structure in urine, even though the upper limit of kidney pore size for filtration is generally 5.5 nm. This suggests that the larger RNA nanoparticles slipped like rubber and amoeba through filtration pores, then returned to their original size and shape in urin.
Overall, Guo says, we believe these findings further support the development of RNA nanoparticles for targeted delivery of anticancer drugs or therapeutic RNA.
Grants from the National Institutes of Health (EB019036, CA151648 and CA207946) supported this research.
Other researchers involved in this study were Chiran Ghimire, Hongzhi Wang, Hui Li, Mario Vieweger and Congcong Xu, The Ohio State University.
About the OSUCCC James:
The Ohio State University Comprehensive Cancer Center Arthur G. James Cancer Hospital and Richard J. Solove Research Institute strives to create a cancer-free world by integrating scientific research with excellence in education and patient-centered care, a strategy that leads to better methods of prevention, detection and treatment. Ohio State is one of only 51 National Cancer Institute (NCI)-designated Comprehensive Cancer Centers and one of only a few centers funded by the NCI to conduct both phase I and phase II clinical trials on novel anticancer drugs sponsored by the NCI.
As the cancer programs 356-bed adult patient-care component, The James is one of the top cancer hospitals in the nation as ranked byU.S. News & World Reportand has achieved Magnet designation, the highest honor an organization can receive for quality patient care and professional nursing practice. With 21 floors and more than 1.1 million square feet, The James is a transformational facility that fosters collaboration and integration of cancer research and clinical cancer care.
The Nanomedicine Market by revenue is expected to grow at a CAGR of over 8.5% during the forecast period 20202027 and is poised to reach US$XX Million in terms of Value.We at Decisive Markets Insights appreciate those firms which are actually interested in purchasing the Nanomedicine report. There has been a recent developments in the above market which is going to impact your revenues big time and help you gain an edge over the competition.
Take first step by requesting for a discount which will vary between 15% to 25% depending on how soon you require to buy the report.
To inquire about the discount, kindly fill the form by clicking on the link below:-https://decisivemarketsinsights.com/nanomedicine-market/16196006/request-discount
Summary of the Report
Increasing demand, rising product acceptance and improving research and development are some of the key factors boosting the growth of the market. The market is growing at a significant growth rate at present and is expected to remain so during the forecast period as well.
To avail Sample Copy of report, visit @ https://decisivemarketsinsights.com/nanomedicine-market/16196006/request-sample
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):Regenerative MedicineIn-vitro & In-vivo DiagnosticsVaccinesDrug Delivery
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):GE HealthcareJohnson & JohnsonMallinckrodt plcMerck & Co. Inc.Nanosphere Inc.Pfizer Inc.Sigma-Tau Pharmaceuticals Inc.Smith & Nephew PLCStryker CorpTeva Pharmaceutical Industries Ltd.UCB (Union chimique belge) S.A
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):Clinical CardiologyUrologyGeneticsOrthopedicsOphthalmology
Nanomedicine Market Scope and Segmentation of the Market
The key segments covered in the report are mentioned below:
By type By Market By Application By End-Use By Geography
The reports regional analysis includes countries in Asia, North America, Europe, South America, Central America, the Middle East and Africa. We also covered countries such as France, Singapore, South America, Canada, Russia, Mexico, the United States, Italy, the Middle East, Central America, Japan, the United Kingdom, India, Germany, Africa, Germany, Africa, China, South Korea, and, among others, Taiwan in these big geographies. The year-on-year growth is given for all segments and sub-segments from 2019 to 2027.
If you want to inquire before buying, kindly click on the link @ https://decisivemarketsinsights.com/nanomedicine-market/16196006/pre-order-enquiry
Nanomedicine Market Overview, Key Trends Market Dynamics
Some of the main factors driving the growth of the market are growing demand, increasing product acceptance and improving research and development. The market is currently rising at a substantial growth rate and is expected to remain so throughout the forecast period as well. The market appears to be marginally affected by COVID -19 at the moment; however, the market is expected to recover its normal pace over time in the coming years. Competitive landscape, study of market share, size, outlook and competitive landscape.
Regional Coverage of Global Nanomedicine Market
North America US, Mexico, Canada Europe Russia, Ukraine, France, Spain, Sweden, Norway, Germany, Finland, Poland, Italy, United Kingdom, Greece, Austria, Denmark, Switzerland, Netherlands, Belgium, Turkey, Luxembourg Asia-Pacific China, Japan, India, Australia, South Korea, Taiwan, Malaysia, Philippines, Thailand, Singapore South America- Brazil, Argentina, Peru, Chile Middle East and Africa Bahrain, Egypt, Israel, Kuwait, Qatar, Saudi Arabia, United Arab Emirates, South Africa
COVID -19 Impact Analysis
The report also offers a detailed insight of COVID-19 impact analysis: Before COVID-19 Present Scenario Post recovery of COVID-19
Table of Content
Customization can be availed on Request:
Chapter 1: Introduction and ScopeChapter 2: Key Company ProfilesChapter 3: Market Descriptions, Share and Forecast across type, application and geographyChapter 4: Market Descriptions of Asia Pacific regionChapter 5: Market Descriptions of Europe regionChapter 6: Market Descriptions of Asia Pacific regionChapter 7: Market Descriptions of North America regionChapter 8: Market Descriptions of Middle East and Africa regionChapter 9: landscapes of the marketChapter 10: Key OpportunitiesChapter 11: Strategies by the key players
Key Pointers of the Report
Decisive Markets Insights advises what your approach should be.Key winning techniques embraced by the major playersMarket analysis from 360 degree perspectivesEstimation and Prognosis, 2020-2027Market growth rate and market size from 2020 to 2027An added portion in the study was COVID-19 impact analysis.
Additional Pointers of the Report:
Market Attractiveness Analysis SWOT Analysis Porters Five Analysis PEST Analysis Value Chain Analysis
Kindly contact us and our expert will get back to you within 30 minutes:
Decisive Markets InsightsSunil KumarSales HeadEmail [emailprotected]US +18317045538UK +441256636046
Global Nanorobotics Market was valued at US$ 3.7 Bn in 2018 and is expected to reach US$ 9.2Bn by 2026, at a CAGR of 12.06%during a forecast period.
Developments in nanotechnology coupled with demand for minimally aggressive procedures are expected to drive market growth over the forecast period. Nanobots possess likely in the medical sector for destroying cancerous cells at the genetic level. Increasing support for nanomedicine by many nations and the increasing geriatric population are factors which can augur market demand.
REQUEST FOR FREE SAMPLE REPORT:https://www.maximizemarketresearch.com/request-sample/30888
The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis.
Utilization of nanobots in the ranostics can be beneficial for the market in the near future. A rise in miniaturization and demand for automation across various sectors are anticipated to fuel market growth. Training of new personnel to use nanobots can restrain market growth in the upcoming years.Nanomedicine application segment to grow at the highest CAGR during the forecast period. Nanorobotics is widely used in nanomedicine owning to its healthcare features. The large share of this application aspects to the large level of commercialization in the healthcare sector for drug delivery, in vivo imaging, biomaterial, in vitro diagnostic, active implants, and drug therapy.
North America region accounted for the largest share of 12.2%, in terms of value, of the nanorobotics market globally. Presence of many nanotechnology companies, well-developed healthcare infrastructure, and government initiatives to create patient awareness are factors driving the market. The U.S is anticipated to contribute to market revenue owing to the increase in cardiovascular diseases and the rising elderly populace.
Europe follows North America as the second biggest nanorobotics market. Presence of chronic diseases and the burgeoning population are factors expected to indicate the Europe nanobots market. Establishment of organizations to develop standards pertaining to nanotechnology can expand market growth. In 2018, DNA-Robotics, an organization including 12 European companies, has outlined steps to expedite production of nanobots on a large scale. These standards can help scale the market exponentially in the upcoming years.
A recent development in nanorobotics market: In March 2018, Thermo Fisher Scientific acquired Gatan, an exclusively owned subsidiary of Roper Technologies. Gatan is an electron microscopy solutions provider in the U.S, which accompaniments the Thermo Fisher Scientifics electron microscopy solutions business.In March 2017, Oxford Instruments (U.K) Asylum Research introduced its new SurfRider HQ-Series of high quality, budget-priced AFM probes, which are also existing in a model suitable for nanomechanical image mode.
The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding Global Nanorobotics Market dynamics, structure by identifying and analyzing the market segments and project the global market size. Further, the report also focuses on the competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence. The report also provides PEST analysis, PORTERs analysis, SWOT analysis to address the question of shareholders to prioritizing the efforts and investment in the near future to the emerging segment in the Global Nanorobotics Market.
DO INQUIRY BEFORE PURCHASING REPORT HERE:https://www.maximizemarketresearch.com/inquiry-before-buying/30888
Scope of the Global Nanorobotics Market
Global Nanorobotics Market, By Type
Nanomanipulatoro Electron Microscope (EM) Scanning Electron Microscope (SEM) Transmission Electron Microscope (TEM)o Scanning Probe Microscope (SPM) Atomic Force Microscopes (AFM) Scanning Tunneling Microscope (STM) Bio-Nanorobotics Magnetically Guided Bacteria-BasedGlobal Nanorobotics Market, By Application
Nanomedicine Biomedical Mechanical OthersGlobal Nanorobotics Market, By Region
North America Europe Asia Pacific Middle East and Africa South AmericaKey players operating in Global Nanorobotics Market:
Bruker JEOL Thermo Fisher Scientific Ginkgo Bioworks Oxford Instruments EV Group Imina Technologies Toronto Nano Instrumentation KlockeNanotechnik KleindiekNanotechnik Xidex Synthace Park Systems Smaract Nanonics ImagingKey Innovators:
Novascan Technologies Angstrom Advanced Hummingbird Scientific NT-MDT Spectrum Instruments Witec
MAJOR TOC OF THE REPORT
Chapter One: Nanorobotics Market Overview
Chapter Two: Manufacturers Profiles
Chapter Three: Global Nanorobotics Market Competition, by Players
Chapter Four: Global Nanorobotics Market Size by Regions
Chapter Five: North America Nanorobotics Revenue by Countries
Chapter Six: Europe Nanorobotics Revenue by Countries
Chapter Seven: Asia-Pacific Nanorobotics Revenue by Countries
Chapter Eight: South America Nanorobotics Revenue by Countries
Chapter Nine: Middle East and Africa Revenue Nanorobotics by Countries
Chapter Ten: Global Nanorobotics Market Segment by Type
Chapter Eleven: Global Nanorobotics Market Segment by Application
Chapter Twelve: Global Nanorobotics Market Size Forecast (2019-2026)
Browse Full Report with Facts and Figures of Nanorobotics Market Report at:https://www.maximizemarketresearch.com/market-report/global-nanorobotics-market/30888/
About Us:
Maximize Market Research provides B2B and B2C market research on 20,000 high growth emerging technologies & opportunities in Chemical, Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.
Contact info:
Name: Vikas Godage
Organization: MAXIMIZE MARKET RESEARCH PVT. LTD.
Email: [emailprotected]
Contact: +919607065656/ +919607195908
Website:www.maximizemarketresearch.com
See the original post here:
Global Nanorobotics Market : Industry Analysis and Forecast (2019-2026) by Type, Application, and Region - Galus Australis
The global Nanomedicine market focuses on encompassing major statistical evidence for the Nanomedicine industry as it offers our readers a value addition on guiding them in encountering the obstacles surrounding the market. A comprehensive addition of several factors such as global distribution, manufacturers, market size, and market factors that affect the global contributions are reported in the study. In addition the Nanomedicine study also shifts its attention with an in-depth competitive landscape, defined growth opportunities, market share coupled with product type and applications, key companies responsible for the production, and utilized strategies are also marked.
This intelligence and 2026 forecasts Nanomedicine industry report further exhibits a pattern of analyzing previous data sources gathered from reliable sources and sets a precedented growth trajectory for the Nanomedicine market. The report also focuses on a comprehensive market revenue streams along with growth patterns, analytics focused on market trends, and the overall volume of the market.
Moreover, the Nanomedicine report describes the market division based on various parameters and attributes that are based on geographical distribution, product types, applications, etc. The market segmentation clarifies further regional distribution for the Nanomedicine market, business trends, potential revenue sources, and upcoming market opportunities.
Download PDF Sample of Nanomedicine Market report @ https://hongchunresearch.com/request-a-sample/2923
Major Players in Nanomedicine market are:, Fraunhofer ICT-IMM, Tecnalia, Bergmannstrost, CIC biomaGUNE, Bracco, Affilogic, LTFN, GIMAC, Endomagnetics, Materials Research Centre, VITO NV, CIBER-BBN, Istec CNR, Carlina technologies, Cristal Therapeutics, ChemConnection, IMDEA, SwedNanoTech, Grupo Praxis, Vicomtech, DTI, Tekniker, Biotechrabbit, Contipro, , Major Regions that plays a vital role in Nanomedicine market are:, North America, Europe, China, Japan, Middle East & Africa, India, South America, Others
Most important types of Nanomedicine products covered in this report are:, Type 1, Type 2, Type 3, Type 4, Type 5
Brief about Nanomedicine Market Report with [emailprotected] https://hongchunresearch.com/report/Nanomedicine-market-2923
Most widely used downstream fields of Nanomedicine market covered in this report are:, Application 1, Application 2, Application 3, Application 4, Application 5
The Nanomedicine market study further highlights the segmentation of the Nanomedicine industry on a global distribution. The report focuses on regions of North America, Europe, Asia, and the Rest of the World in terms of developing business trends, preferred market channels, investment feasibility, long term investments, and environmental analysis. The Nanomedicine report also calls attention to investigate product capacity, product price, profit streams, supply to demand ratio, production and market growth rate, and a projected growth forecast.
In addition, the Nanomedicine market study also covers several factors such as market status, key market trends, growth forecast, and growth opportunities. Furthermore, we analyze the challenges faced by the Nanomedicine market in terms of global and regional basis. The study also encompasses a number of opportunities and emerging trends which are considered by considering their impact on the global scale in acquiring a majority of the market share.
The study encompasses a variety of analytical resources such as SWOT analysis and Porters Five Forces analysis coupled with primary and secondary research methodologies. It covers all the bases surrounding the Nanomedicine industry as it explores the competitive nature of the market complete with a regional analysis.
Some Point of Table of Content:
Chapter One: Nanomedicine Introduction and Market Overview
Chapter Two: Industry Chain Analysis
Chapter Three: Global Nanomedicine Market, by Type
Chapter Four: Nanomedicine Market, by Application
Chapter Five: Global Nanomedicine Production, Value ($) by Region (2014-2019)
Chapter Six: Global Nanomedicine Production, Consumption, Export, Import by Regions (2014-2019)
Chapter Seven: Global Nanomedicine Market Status and SWOT Analysis by Regions
Chapter Eight: Competitive Landscape
Chapter Nine: Global Nanomedicine Market Analysis and Forecast by Type and Application
Chapter Ten: Nanomedicine Market Analysis and Forecast by Region
Chapter Eleven: New Project Feasibility Analysis
Chapter Twelve: Research Finding and Conclusion
Chapter Thirteen: Appendix continued
List of tablesList of Tables and Figures
Figure Product Picture of Nanomedicine
Table Product Specification of Nanomedicine
Figure Market Concentration Ratio and Market Maturity Analysis of Nanomedicine
Figure Global Nanomedicine Value ($) and Growth Rate from 2014-2024
Table Different Types of Nanomedicine
Figure Global Nanomedicine Value ($) Segment by Type from 2014-2019
Figure Nanomedicine Type 1 Picture
Figure Nanomedicine Type 2 Picture
Figure Nanomedicine Type 3 Picture
Figure Nanomedicine Type 4 Picture
Figure Nanomedicine Type 5 Picture
Table Different Applications of Nanomedicine
Figure Global Nanomedicine Value ($) Segment by Applications from 2014-2019
Figure Application 1 Picture
Figure Application 2 Picture
Figure Application 3 Picture
Figure Application 4 Picture
Figure Application 5 Picture
Table Research Regions of Nanomedicine
Figure North America Nanomedicine Production Value ($) and Growth Rate (2014-2019)
Figure Europe Nanomedicine Production Value ($) and Growth Rate (2014-2019)
Table China Nanomedicine Production Value ($) and Growth Rate (2014-2019)
Table Japan Nanomedicine Production Value ($) and Growth Rate (2014-2019)continued
About HongChun Research:HongChun Research main aim is to assist our clients in order to give a detailed perspective on the current market trends and build long-lasting connections with our clientele. Our studies are designed to provide solid quantitative facts combined with strategic industrial insights that are acquired from proprietary sources and an in-house model.
Contact Details:Jennifer GrayManager Global Sales+ 852 8170 0792[emailprotected]
NOTE: Our report does take into account the impact of coronavirus pandemic and dedicates qualitative as well as quantitative sections of information within the report that emphasizes the impact of COVID-19.
As this pandemic is ongoing and leading to dynamic shifts in stocks and businesses worldwide, we take into account the current condition and forecast the market data taking into consideration the micro and macroeconomic factors that will be affected by the pandemic.
Go here to read the rest:
COVID-19 Impact on Global and Regional Nanomedicine Industry Production, Sales and Consumption Status and Prospects Professional Market Research...
Nanomedicine Market Scope of the Report:
Factors and Nanomedicine Market execution are analyzed using quantitative and qualitative approaches to give a consistent picture of current and future trends in the boom. The study also allows for a detailed market analysis focused primarily on geographic locations. The Global Nanomedicine Market Report offers statistical graphs, estimates, and collateral that explain the state of specific trade within the local and global scenarios.
The worldwide market for Nanomedicine is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2025, from xx million US$ in 2018, according to a new study.
This report focuses on the Nanomedicine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
For more insights into the Market, request a sample of this report (Including Full TOC, List of Tables & Figures, Chart) @ https://www.researchmoz.com/enquiry.php?type=S&repid=2734725&source=atm
segment by Type, the product can be split intoQuantum dotsNanoparticlesNanoshellsNanotubesNanodevicesMarket segment by Application, split intooncologyInfectious diseasesCardiologyOrthopedicsOthers
Market segment by Regions/Countries, this report coversNorth AmericaEuropeChinaJapanSoutheast AsiaIndiaCentral & South America
For Information On The Research Approach Used In The Report, Ask to Our Industry [emailprotected] https://www.researchmoz.com/enquiry.php?type=E&repid=2734725&source=atm
Reasons to Purchase this Nanomedicine Market Report:
* Analyzing the outlook of the market with the recent trends and SWOT analysis
* Market dynamics scenario, along with growth opportunities of the market in the years to come
* Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and non-economic aspects
* Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
* Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
* Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
* Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
* 1-year analyst support, along with the data support in excel format.
You can Buy This Report from Here @ https://www.researchmoz.com/checkout?rep_id=2734725&licType=S&source=atm
The Nanomedicine Market report has 150 tables and figures browse the report description and TOC:
Table of Contents
1 Study Coverage
1.1 Nanomedicine Product
1.2 Key Market Segments in This Study
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Nanomedicine Market Size Growth Rate by Type
1.5 Market by Application
1.5.1 Global Nanomedicine Market Size Growth Rate by Application
2 Executive Summary
2.1 Global Nanomedicine Market Size
2.1.1 Global Nanomedicine Revenue 2014-2025
2.1.2 Global Nanomedicine Production 2014-2025
2.2 Nanomedicine Growth Rate (CAGR) 2019-2025
2.3 Analysis of Competitive Landscape
2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
2.3.2 Key Nanomedicine Manufacturers
2.3.2.1 Nanomedicine Manufacturing Base Distribution, Headquarters
2.3.2.2 Manufacturers Nanomedicine Product Offered
2.3.2.3 Date of Manufacturers Enter into Nanomedicine Market
2.4 Key Trends for Nanomedicine Markets & Products
3 Market Size by Manufacturers
3.1 Nanomedicine Production by Manufacturers
3.1.1 Nanomedicine Production by Manufacturers
3.1.2 Nanomedicine Production Market Share by Manufacturers
3.2 Nanomedicine Revenue by Manufacturers
3.2.1 Nanomedicine Revenue by Manufacturers (2019-2025)
3.2.2 Nanomedicine Revenue Share by Manufacturers (2019-2025)
3.3 Nanomedicine Price by Manufacturers
3.4 Mergers & Acquisitions, Expansion Plans
More Information.
For More Information Kindly Contact:
ResearchMoz
Mr. Rohit Bhisey,
90 State Street,
Albany NY,
United States 12207
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: [emailprotected]
See the article here:
Nanomedicine Market Revolutionary Trends 2025 The News Brok - The News Brok
Imagine a world in which a tiny nanorobot could deliver a specific cannabinoid directly to your endocannabinoid (ECS) receptors. The nanorobot would be thousands of times smaller than the breadth of a human hair and could carry its small cargo inside a single droplet of liquid to deliver it directly to a target cell such as a cancer cell.
Sound far-fetched? It may be closer than you think, because researchers are making great strides in the fascinating field of nanomedicine.
The cannabis plant contains an amazing group of cannabinoids, terpenes, and flavonoids, and scientists are only beginning to unlock the complex pharmacology and potential of these compounds. Combined with nanomedicine, cannabis has even more potential to treat disease and provide overall health benefits for people.
Scientists can manipulate substances on an atomic scale, in the range of 1-100 nanometers, or one thousand times thinner than a sheet of paper. According to the US Nanotechnology Initiative, substances on the nanoscale have very different properties than bulk substances dounique properties like better electrical conductance, higher strength, and different magnetic properties, light reflection, or chemical reactivity. Nanotechnology can be performed on solids, liquids, or gases to unlock these unique phenomena.
For these reason, nanotechnology applications in medicine offer exciting promise and possibilities, especially when applied to cannabis compounds. Many nanotechnology applications are already in usecomputer circuits made from carbon nanotubes allow for far greater computing power, and nanoparticles are already being used in pharmaceuticals to improve absorption.
Researchers work on all kinds of aspects of nanotechnology, such as finding the best substance for nanoparticles, the best shape for a nanoparticle for a specific delivery, and the best transfer mechanisms for specific drugs. Nanoparticles can generate heat, deliver stem cells, be radioactive or metallic, and so much more.
While many applications are still only imagined by scientists, at its full potential, nanotechnology could be the next medical revolution, vastly changing how diseases are detected and treated.
One of the best applications of nanomedicine is in the area of drug delivery, whereby nanoparticles deliver substances directly to specific cells, like diseased cancer cells. Researchers can engineer nanoparticles to be attracted to a diseased cell and limit the ability to bind with and therefore damage healthy cells.
Scientists at MIT and other institutions have successfully used specific nanoparticles to deliver drugs to tumors. Even more interesting is that nanoparticles are developed to work togetherwhile one locates a tumor, another can use the signal from the first to effectively carry the drug to its intended target.
In one interesting application, scientists have created a nanoparticle that looks for hydrogen peroxide present in inflamed tissue, then it releases a drug in that environment to target heart disease.
There is great promise that nanotechnology and cannabinoids can make an impact on diseases like cancer, multiple sclerosis, Parkinsons, diabetes, and a wide range of serious inflammatory diseases.
Nanotechnology can help identify a disease at an early stage, perhaps even when a single cell has gone awry, and then deliver a targeted cannabinoid to correct a cells behavior, thus stopping the disease in its tracks. It may even be possible for a nanorobot to target a specific endocannabinoid receptor to shut down the entire inflammatory process for the betterment of a patient.
Cannabinoid nanodelivery systems have entered the research mainstream, with scientists working on biologically engineered cannabinoids and other nanoparticles to be transported to cells, and by creating nanocarrier transport substances out of metallics or other substances.
Delivery system research also touches on improving bioavailabilitythe rate at which the active substance of a drug enters the bloodstreamas well as improving the physical stability of nanoparticles and optimizing routes of administration, including injection, pills, or sublingual drops.
A nanotechnology-based targeted drug delivery system can be formulated to deliver cannabinoids directly to endocannabinoid receptors, where the magic happens. Cannabinoids can be packed inside a nanoparticle and carried to its intended target without degradation and with a controlled release.
For example, nanoemulsions are already used in the food industry to deliver probiotics or other bioactive ingredients in a very controlled release. These nanoemulsions use a combination of two liquids that dont normally combinesuch as oil and waterto serve as a barrier to chemical degradation for the cannabinoid while on its journey through the body.
Other encapsulation methods can help with potency issues by increasing absorption, they can help decrease side effects, and they can help cover a substances bitter taste.
Specific cannabis strains could even have tailored therapeutic profiles, and cannabinoids could be bioengineered to produce enhanced effects.
Scientists envision a superclass of cannabinoid nanocarriers that have potential to treat a wide array of endocannabinoid insufficiency issues and thus a wide variety of diseases.
In one example, researchers are looking at novel ways to deliver substances across the difficult blood-brain barrier. This barrier is the bodys built-in defense mechanism to protect the brain, so the ability to transport substances across it directly affects a treatments efficacy.
To this end, scientists are engineering lipid nanocapsules decorated with minute cannabinoids like CBD as novel therapies for diseases of the central nervous system.
Nanotechnology has already transformed drug delivery in profound ways, and cannabinoid delivery is part of this exciting future. There are challenges, of course. Cannabinoids quickly degrade in water and are susceptible to other kinds of degradation, and that presents delivery issues.
More recent discoveries, including the decoding of the cannabis genome, discovery of the main CB1R and CB2R receptors within the human endocannabinoid system (ECS), and discovery of other receptors, are also foundational efforts that contribute to cannabinoid nanotechnology.
The latest research shows great progress in the formulation of targeted cannabinoid-nanocarrier delivery systems, and as such may provide key therapies particularly for central nervous system disorders. As scientists continue to make improvements in both bio-efficacy and bioavailability, cannabis nanotechnology represents an exciting and brave new world.
Read the rest here:
How can nanomedicine be applied to cannabis? - Leafly
LOS ANGELES, United States: QY Research has recently published a report, titled Global Oral Contrast Agent Market Research Report 2020. The research report gives the potential headway openings that prevails in the global market. The report is amalgamated depending on research procured from primary and secondary information. The global Oral Contrast Agent market is relied upon to develop generously and succeed in volume and value during the predicted time period. Moreover, the report gives nitty gritty data on different manufacturers, region, and products which are important to totally understanding the market.
Key Companies/Manufacturers operating in the global Oral Contrast Agent market include: GE Healthcare (US), Bracco Imaging (Italy), Bayer HealthCare (Germany), Guerbet (France), Lantheus (US), Daiichi Sankyo (Japan), Unijules Life Sciences (India), J.B. Chemicals and Pharmaceuticals (India), Spago Nanomedicine (Sweden), Taejoon Pharm (South Korea), Jodas (India), Magnus Health (India)
Get PDF Sample Copy of the Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) :
https://www.qyresearch.com/sample-form/form/2041698/global-oral-contrast-agent-market
Segmental Analysis
Both developed and emerging regions are deeply studied by the authors of the report. The regional analysis section of the report offers a comprehensive analysis of the global Oral Contrast Agent market on the basis of region. Each region is exhaustively researched about so that players can use the analysis to tap into unexplored markets and plan powerful strategies to gain a foothold in lucrative markets.
Global Oral Contrast Agent Market Segment By Type:
Barium-based Contrast MediaIodinated Contrast MediaGadolinium-based Contrast MediaMicrobubble Contrast Media
Global Oral Contrast Agent Market Segment By Application:
Cardiovascular DisordersCancerGastrointestinal DisordersMusculoskeletal DisordersNeurological DisordersNephrological Disorders
Competitive Landscape
Competitor analysis is one of the best sections of the report that compares the progress of leading players based on crucial parameters, including market share, new developments, global reach, local competition, price, and production. From the nature of competition to future changes in the vendor landscape, the report provides in-depth analysis of the competition in the global Oral Contrast Agent market.
Key companies operating in the global Oral Contrast Agent market include GE Healthcare (US), Bracco Imaging (Italy), Bayer HealthCare (Germany), Guerbet (France), Lantheus (US), Daiichi Sankyo (Japan), Unijules Life Sciences (India), J.B. Chemicals and Pharmaceuticals (India), Spago Nanomedicine (Sweden), Taejoon Pharm (South Korea), Jodas (India), Magnus Health (India)
Key questions answered in the report:
For Discount, Customization in the Report: https://www.qyresearch.com/customize-request/form/2041698/global-oral-contrast-agent-market
TOC
1 Oral Contrast Agent Market Overview1.1 Product Overview and Scope of Oral Contrast Agent1.2 Oral Contrast Agent Segment by Type1.2.1 Global Oral Contrast Agent Sales Growth Rate Comparison by Type (2021-2026)1.2.2 Barium-based Contrast Media1.2.3 Iodinated Contrast Media1.2.4 Gadolinium-based Contrast Media1.2.5 Microbubble Contrast Media1.3 Oral Contrast Agent Segment by Application1.3.1 Oral Contrast Agent Sales Comparison by Application: 2020 VS 20261.3.2 Cardiovascular Disorders1.3.3 Cancer1.3.4 Gastrointestinal Disorders1.3.5 Musculoskeletal Disorders1.3.6 Neurological Disorders1.3.7 Nephrological Disorders1.4 Global Oral Contrast Agent Market Size Estimates and Forecasts1.4.1 Global Oral Contrast Agent Revenue 2015-20261.4.2 Global Oral Contrast Agent Sales 2015-20261.4.3 Oral Contrast Agent Market Size by Region: 2020 Versus 20261.5 Oral Contrast Agent Industry1.6 Oral Contrast Agent Market Trends 2 Global Oral Contrast Agent Market Competition by Manufacturers2.1 Global Oral Contrast Agent Sales Market Share by Manufacturers (2015-2020)2.2 Global Oral Contrast Agent Revenue Share by Manufacturers (2015-2020)2.3 Global Oral Contrast Agent Average Price by Manufacturers (2015-2020)2.4 Manufacturers Oral Contrast Agent Manufacturing Sites, Area Served, Product Type2.5 Oral Contrast Agent Market Competitive Situation and Trends2.5.1 Oral Contrast Agent Market Concentration Rate2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)2.6 Manufacturers Mergers & Acquisitions, Expansion Plans2.7 Primary Interviews with Key Oral Contrast Agent Players (Opinion Leaders) 3 Oral Contrast Agent Retrospective Market Scenario by Region3.1 Global Oral Contrast Agent Retrospective Market Scenario in Sales by Region: 2015-20203.2 Global Oral Contrast Agent Retrospective Market Scenario in Revenue by Region: 2015-20203.3 North America Oral Contrast Agent Market Facts & Figures by Country3.3.1 North America Oral Contrast Agent Sales by Country3.3.2 North America Oral Contrast Agent Sales by Country3.3.3 U.S.3.3.4 Canada3.4 Europe Oral Contrast Agent Market Facts & Figures by Country3.4.1 Europe Oral Contrast Agent Sales by Country3.4.2 Europe Oral Contrast Agent Sales by Country3.4.3 Germany3.4.4 France3.4.5 U.K.3.4.6 Italy3.4.7 Russia3.5 Asia Pacific Oral Contrast Agent Market Facts & Figures by Region3.5.1 Asia Pacific Oral Contrast Agent Sales by Region3.5.2 Asia Pacific Oral Contrast Agent Sales by Region3.5.3 China3.5.4 Japan3.5.5 South Korea3.5.6 India3.5.7 Australia3.5.8 Taiwan3.5.9 Indonesia3.5.10 Thailand3.5.11 Malaysia3.5.12 Philippines3.5.13 Vietnam3.6 Latin America Oral Contrast Agent Market Facts & Figures by Country3.6.1 Latin America Oral Contrast Agent Sales by Country3.6.2 Latin America Oral Contrast Agent Sales by Country3.6.3 Mexico3.6.3 Brazil3.6.3 Argentina3.7 Middle East and Africa Oral Contrast Agent Market Facts & Figures by Country3.7.1 Middle East and Africa Oral Contrast Agent Sales by Country3.7.2 Middle East and Africa Oral Contrast Agent Sales by Country3.7.3 Turkey3.7.4 Saudi Arabia3.7.5 U.A.E 4 Global Oral Contrast Agent Historic Market Analysis by Type4.1 Global Oral Contrast Agent Sales Market Share by Type (2015-2020)4.2 Global Oral Contrast Agent Revenue Market Share by Type (2015-2020)4.3 Global Oral Contrast Agent Price Market Share by Type (2015-2020)4.4 Global Oral Contrast Agent Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Global Oral Contrast Agent Historic Market Analysis by Application5.1 Global Oral Contrast Agent Sales Market Share by Application (2015-2020)5.2 Global Oral Contrast Agent Revenue Market Share by Application (2015-2020)5.3 Global Oral Contrast Agent Price by Application (2015-2020) 6 Company Profiles and Key Figures in Oral Contrast Agent Business6.1 GE Healthcare (US)6.1.1 Corporation Information6.1.2 GE Healthcare (US) Description, Business Overview and Total Revenue6.1.3 GE Healthcare (US) Oral Contrast Agent Sales, Revenue and Gross Margin (2015-2020)6.1.4 GE Healthcare (US) Products Offered6.1.5 GE Healthcare (US) Recent Development6.2 Bracco Imaging (Italy)6.2.1 Bracco Imaging (Italy) Corporation Information6.2.2 Bracco Imaging (Italy) Description, Business Overview and Total Revenue6.2.3 Bracco Imaging (Italy) Oral Contrast Agent Sales, Revenue and Gross Margin (2015-2020)6.2.4 Bracco Imaging (Italy) Products Offered6.2.5 Bracco Imaging (Italy) Recent Development6.3 Bayer HealthCare (Germany)6.3.1 Bayer HealthCare (Germany) Corporation Information6.3.2 Bayer HealthCare (Germany) Description, Business Overview and Total Revenue6.3.3 Bayer HealthCare (Germany) Oral Contrast Agent Sales, Revenue and Gross Margin (2015-2020)6.3.4 Bayer HealthCare (Germany) Products Offered6.3.5 Bayer HealthCare (Germany) Recent Development6.4 Guerbet (France)6.4.1 Guerbet (France) Corporation Information6.4.2 Guerbet (France) Description, Business Overview and Total Revenue6.4.3 Guerbet (France) Oral Contrast Agent Sales, Revenue and Gross Margin (2015-2020)6.4.4 Guerbet (France) Products Offered6.4.5 Guerbet (France) Recent Development6.5 Lantheus (US)6.5.1 Lantheus (US) Corporation Information6.5.2 Lantheus (US) Description, Business Overview and Total Revenue6.5.3 Lantheus (US) Oral Contrast Agent Sales, Revenue and Gross Margin (2015-2020)6.5.4 Lantheus (US) Products Offered6.5.5 Lantheus (US) Recent Development6.6 Daiichi Sankyo (Japan)6.6.1 Daiichi Sankyo (Japan) Corporation Information6.6.2 Daiichi Sankyo (Japan) Description, Business Overview and Total Revenue6.6.3 Daiichi Sankyo (Japan) Oral Contrast Agent Sales, Revenue and Gross Margin (2015-2020)6.6.4 Daiichi Sankyo (Japan) Products Offered6.6.5 Daiichi Sankyo (Japan) Recent Development6.7 Unijules Life Sciences (India)6.6.1 Unijules Life Sciences (India) Corporation Information6.6.2 Unijules Life Sciences (India) Description, Business Overview and Total Revenue6.6.3 Unijules Life Sciences (India) Oral Contrast Agent Sales, Revenue and Gross Margin (2015-2020)6.4.4 Unijules Life Sciences (India) Products Offered6.7.5 Unijules Life Sciences (India) Recent Development6.8 J.B. Chemicals and Pharmaceuticals (India)6.8.1 J.B. Chemicals and Pharmaceuticals (India) Corporation Information6.8.2 J.B. Chemicals and Pharmaceuticals (India) Description, Business Overview and Total Revenue6.8.3 J.B. Chemicals and Pharmaceuticals (India) Oral Contrast Agent Sales, Revenue and Gross Margin (2015-2020)6.8.4 J.B. Chemicals and Pharmaceuticals (India) Products Offered6.8.5 J.B. Chemicals and Pharmaceuticals (India) Recent Development6.9 Spago Nanomedicine (Sweden)6.9.1 Spago Nanomedicine (Sweden) Corporation Information6.9.2 Spago Nanomedicine (Sweden) Description, Business Overview and Total Revenue6.9.3 Spago Nanomedicine (Sweden) Oral Contrast Agent Sales, Revenue and Gross Margin (2015-2020)6.9.4 Spago Nanomedicine (Sweden) Products Offered6.9.5 Spago Nanomedicine (Sweden) Recent Development6.10 Taejoon Pharm (South Korea)6.10.1 Taejoon Pharm (South Korea) Corporation Information6.10.2 Taejoon Pharm (South Korea) Description, Business Overview and Total Revenue6.10.3 Taejoon Pharm (South Korea) Oral Contrast Agent Sales, Revenue and Gross Margin (2015-2020)6.10.4 Taejoon Pharm (South Korea) Products Offered6.10.5 Taejoon Pharm (South Korea) Recent Development6.11 Jodas (India)6.11.1 Jodas (India) Corporation Information6.11.2 Jodas (India) Oral Contrast Agent Description, Business Overview and Total Revenue6.11.3 Jodas (India) Oral Contrast Agent Sales, Revenue and Gross Margin (2015-2020)6.11.4 Jodas (India) Products Offered6.11.5 Jodas (India) Recent Development6.12 Magnus Health (India)6.12.1 Magnus Health (India) Corporation Information6.12.2 Magnus Health (India) Oral Contrast Agent Description, Business Overview and Total Revenue6.12.3 Magnus Health (India) Oral Contrast Agent Sales, Revenue and Gross Margin (2015-2020)6.12.4 Magnus Health (India) Products Offered6.12.5 Magnus Health (India) Recent Development 7 Oral Contrast Agent Manufacturing Cost Analysis7.1 Oral Contrast Agent Key Raw Materials Analysis7.1.1 Key Raw Materials7.1.2 Key Raw Materials Price Trend7.1.3 Key Suppliers of Raw Materials7.2 Proportion of Manufacturing Cost Structure7.3 Manufacturing Process Analysis of Oral Contrast Agent7.4 Oral Contrast Agent Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers8.1 Marketing Channel8.2 Oral Contrast Agent Distributors List8.3 Oral Contrast Agent Customers 9 Market Dynamics9.1 Market Trends9.2 Opportunities and Drivers9.3 Challenges9.4 Porters Five Forces Analysis 10 Global Market Forecast10.1 Global Oral Contrast Agent Market Estimates and Projections by Type10.1.1 Global Forecasted Sales of Oral Contrast Agent by Type (2021-2026)10.1.2 Global Forecasted Revenue of Oral Contrast Agent by Type (2021-2026)10.2 Oral Contrast Agent Market Estimates and Projections by Application10.2.1 Global Forecasted Sales of Oral Contrast Agent by Application (2021-2026)10.2.2 Global Forecasted Revenue of Oral Contrast Agent by Application (2021-2026)10.3 Oral Contrast Agent Market Estimates and Projections by Region10.3.1 Global Forecasted Sales of Oral Contrast Agent by Region (2021-2026)10.3.2 Global Forecasted Revenue of Oral Contrast Agent by Region (2021-2026)10.4 North America Oral Contrast Agent Estimates and Projections (2021-2026)10.5 Europe Oral Contrast Agent Estimates and Projections (2021-2026)10.6 Asia Pacific Oral Contrast Agent Estimates and Projections (2021-2026)10.7 Latin America Oral Contrast Agent Estimates and Projections (2021-2026)10.8 Middle East and Africa Oral Contrast Agent Estimates and Projections (2021-2026) 11 Research Finding and Conclusion 12 Methodology and Data Source12.1 Methodology/Research Approach12.1.1 Research Programs/Design12.1.2 Market Size Estimation12.1.3 Market Breakdown and Data Triangulation12.2 Data Source12.2.1 Secondary Sources12.2.2 Primary Sources12.3 Author List12.4 Disclaimer
About Us:
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.
Read this article:
Trending Now: Oral Contrast Agent Market Detailed Analysis of Current Industry Figures With Forecasts Growth by 2026| GE Healthcare (US), Bracco...
Global Nanomedicine Market 2020-2027
GlobalNanomedicine Market Global Drivers, Restraints, Opportunities, Trends, and Forecasts up to 2027. Market Over viewing the present digitized world, 80% of the data generated is unstructured. Organizations are usingNanomedicine technology to unravel the meaning of such data to leverage business strategies and opportunities. A myriad of unstructured data is available online in the form of audio content, visual content and social footprints.
The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2020-2027.The Report scope furnishes with vital statistics about the current market status and manufacturers. It analyzes the in-depth business by considering different aspects, direction for companies, and strategy in the industry.
Our new sample is updated which correspond in new report showing impact of COVID-19 on Industry
The Key Players Profiled In the Market Include
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.)
The Key Players | * GE Healthcare, * Johnson& Johnson, * Mallinckrodt plc, * Merck& Co. Inc., * Nanosphere Inc., and * Pfizer Inc.
For Better Understanding, Download Sample PDF Copy of Nanomedicine Market Research Report @
After analyzing the report and all the aspects of the new investment projects, it is assessed the overall research and closure offered. The analysis of each segment in-detailed with various point views; that include the availability of data, facts, and figures, past performance, trends, and way of approaching in the market.The progressive growth in Nanomedicine Market report also covers the in-depth analysis of the market dynamics, price, and forecast parameters which also include the demand, profit margin, supply and cost for the industry.
Key question and answered in the report include:
What will the market size and the growth rate be in 2027?
What are the key factors driving the GlobalNanomedicine Market?
What are the key market trends impacting the growth of the GlobalNanomedicine Market?
What are the challenges to market growth?
Who are the key North vendors in the GlobalNanomedicine Market?
What are the market opportunities and threats faced by the vendors in the GlobalNanomedicine Market?
This report provides pinpoint analysis for changing competitive dynamics. It offers a forward-looking perspective on different factors driving or limiting market growth. It provides a five-year forecast assessed on the basis of how they progressive growth inNanomedicine Market is predicted to grow. It helps in understanding the key product segments and their future and helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments.
Reasons to Buy this Report
Gain detailed insights on theNanomedicine industry trends
Find complete analysis on the market status
Identify theNanomedicine market Counteropportunities and growth segments
Analyze competitive dynamics by evaluating business segments & product portfolios
Facilitate strategy planning and industry dynamics to enhance decision making
The report offers in-depth assessment of the growth and other aspects of theNanomedicine market in important countries (regions), including:
North America
Europe
Asia PacificCounter
Middle East & Africa
Latin America
America Country (United States, Canada)
South America
Asia Country (China, Japan, India, Korea)
Europe Country (Germany, UK, France, Italy)
Other Country (Middle East, Africa, GCC)
Get Complete TOCon this Premium Report, Click Here @
TABLE OF CONTENT
1 Report Overview
2 Global Growth Trends
3 Market Share by Key Players
4 Breakdown Data by Type and Application
5 United States
6 Europe
7 China
8 Japan
9 Southeast Asia
10 India
11 Central & South America
12 International Players Profiles
13 Market Forecast 2020-2027
14 Analysts Viewpoints/Conclusions
15 Appendix
About Author:
Market research is the new buzzword in the market, which helps in understanding the market potential of any product in the market. This helps in understanding the market players and the growth forecast of the products and so the company. This is where market research companies come into the picture. Reports And Markets is not just another company in this domain but is a part of a veteran group called Algoro Research Consultants Pvt. Ltd. It offers premium progressive statistical surveying, market research reports, analysis & forecast data for a wide range of sectors both for the government and private agencies all across the world.
Contact Us:
Sanjay Jain
Manager Partner Relations & International
https://www.reportsandmarkets.com/
Ph: +1-352-353-0818 (US)
This Healthcare Nanotechnology (Nanomedicine) Market research report provide business experts opinion with efficient information on Healthcare Nanotechnology (Nanomedicine) market growth rate, emerging business environments, and the latest business-centric applications. This Healthcare Nanotechnology (Nanomedicine) industry report lists and studies the leading participants also provide insights with strategic industry Analysis of the key factors influencing the market dynamics. Healthcare Nanotechnology (Nanomedicine) market report focuses on to describe and analyze the value, market share, market competition landscape, SWOT analysis, and development plans in the next few years. The report also offers an in-depth analysis of the Healthcare Nanotechnology (Nanomedicine) market with prime emphasis on factors such as drivers, restraints, trends, and opportunities.
Scope of the Report:
As per the , the healthcare nanotechnology (nanomedicine) market includes products that are nanoformulations of the existing drugs or new drugs or are nanobiomaterials. The market is segmented by its application in the medical field, as drug delivery, biomaterials, active implants, diagnostic imaging, tissue regeneration, and other applications. The market is also segmented by its use in the treatment of diseases, like cardiovascular diseases, oncological diseases, neurological diseases, orthopedic diseases, infectious diseases, and other diseases.<
The Report Covers:
For More Information or Query or Customization Before Buying, Visit at https://www.industryresearch.co/enquiry/pre-order-enquiry/14099195
Key Market Trends:
The Growth of Nanomedicine is Expected to Provide High Opportunities for the Treatment of Neurological Diseases, Over the Forecast Period
A large number of brain disorders with neurological and psychological conditions result in short-term and long-term disabilities. Recent years observed a significant number of research studies being published on methods for the synthesis of nanoparticle-encapsulated drugs within in vivo and in vitro studies. The insufficient absorbance of oral drugs administered for a range of neurological conditions, such as Alzheimers disease, Parkinson disease, tumor, neuro-AIDS, among others, opens up the necessity of nanomedicine with stem cell therapy. Some of the registered nanoparticles for the complex CNS treatment are a gold nanoparticle, lipid nanoparticle, and chitosan nanoparticles.
Other than neurological diseases, research-based progress was found in the treatment of cancers, with the scientific communities identifying new metabolic pathways to find better drug combination using nanomedicine.
North America is Expected to Hold the Largest Share in the Market
In the United States, several companies are closely observing the developments in nanostructured materials across various applications in the healthcare industry, including medical devices, to improve efficiency and efficacy. In the United States, the National Nanotechnology Initiative (NNI), which was initiated in 2000, is among the supreme bodies that manage all nanotechnology-related activities. Under the NNI, several agencies are working in collaboration with companies and universities. For instance, nano-manufacturing in Small Business Innovation Research (SBIR) programs were developed for both commercial and public use. Companies are targeting the treatment of several cancer types and infectious diseases through immunotherapy, where nanoemulsion vaccines and drugs play a significant role. In the United States, one of the major challenges associated with nanotechnology is the ability to integrate nanoscale materials into new devices and systems, along with an application of novel properties at the nano-level. Thus, most of the companies are investing in R&D. Nanotechnology is likely to play a significant role in the delivery of drugs. In the recent strategic plan presented by the NNI in 2016, several programs were identified to further advance the research and development programs, over the forecast period.
Key Questions Answered in This Report:
Purchase this Report (Price 4250 USD for single user license) https://www.industryresearch.co/purchase/14099195
Detailed TOC of Healthcare Nanotechnology (Nanomedicine) Market 2019-2024:
1 INTRODUCTION1.1 Study Deliverables1.2 Study Assumptions1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS4.1 Market Overview4.2 Market Drivers4.2.1 Growing Prevalence of Cancer and Genetic and Cardiovascular Diseases4.2.2 Increasing Advancements in Nanoscale Technologies for Diagnostic Procedures4.2.3 Growing Preference for Personalized Medicines4.3 Market Restraints4.3.1 High Cost4.3.2 Stringent Regulations for Commercial Introduction4.4 Porters Five Forces Analysis4.4.1 Threat of New Entrants4.4.2 Bargaining Power of Buyers/Consumers4.4.3 Bargaining Power of Suppliers4.4.4 Threat of Substitute Products4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION5.1 By Application5.1.1 Drug Delivery5.1.2 Biomaterials5.1.3 Active Implants5.1.4 Diagnostic Imaging5.1.5 Tissue Regeneration5.1.6 Other Applications5.2 By Disease5.2.1 Cardiovascular Diseases5.2.2 Oncological Diseases5.2.3 Neurological Diseases5.2.4 Orthopedic Diseases5.2.5 Infectious Diseases5.2.6 Other Diseases5.3 Geography5.3.1 North America5.3.1.1 US5.3.1.2 Canada5.3.1.3 Mexico5.3.2 Europe5.3.2.1 France5.3.2.2 Germany5.3.2.3 UK5.3.2.4 Italy5.3.2.5 Spain5.3.2.6 Rest of Europe5.3.3 Asia-Pacific5.3.3.1 China5.3.3.2 Japan5.3.3.3 India5.3.3.4 Australia5.3.3.5 South Korea5.3.3.6 Rest of Asia-Pacific5.3.4 Middle East & Africa5.3.4.1 GCC5.3.4.2 South Africa5.3.4.3 Rest of Middle East & Africa5.3.5 South America5.3.5.1 Brazil5.3.5.2 Argentina5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE6.1 Company Profiles6.1.1 Sanofi SA6.1.2 Celegene Corporation6.1.3 CytImmune Sciences Inc.6.1.4 Johnson & Johnson6.1.5 Luminex Corporation6.1.6 Merck & Co. Inc.6.1.7 Nanobiotix6.1.8 Pfizer Inc.6.1.9 Starpharma Holdings Limited6.1.10 Taiwan Liposome Company Ltd
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
Contact Us:
Name: Ajay More
Phone: US +14242530807/ UK +44 20 3239 8187
Email: [emailprotected]
Our Other Reports:
WiFi Analytics Solution Market Analysis by Global Size 2020: Company Overview with Top Manufacturers, Competitive Landscape, Growth Rate till 2024
Conventional Metal Forming Machine Tools Market Share and Size Analysis 2020 by Regional Demand Status, Future Growth Rate, Manufacturers, Trends by Market Dynamics and Development Scope till 2026
Broaching Machines Market Size and Share by Top Players 2020 | COVID-19 Impact on Global Industry, Business Opportunities, Growth Trends and Demand till 2026
Seed Inoculants Market Future Growth Rate 2020 | Global Key Players Overview with COVID-19 Impact, Industry Size and Share by Trends, Development Plans till 2026
Air Cargo & Freight Logistics Market Analysis by Global Size 2020: Company Overview with Top Manufacturers, Competitive Landscape, Growth Rate till 2024
Article In Brief
Mice with an open- and closed-traumatic brain injury were injected with immunomodulatory nanoparticles that reduced brain swelling and damage on MRI.
Investigators used a novel approach to prevent the swelling that can occur after traumatic brain injury (TBI) in a mouse model: they injected nanoparticles that trick white blood cells into going after them instead of rushing to the injured brain and causing an inflammatory and immune response.
Mice with TBI that were given three injections of the immunomodulatory nanoparticles beginning two to three hours after injury showed less brain swelling and damage on MRI as compared with mice with TBI that did not get the nanoparticles; the treated mice also performed better on functional tests.
The immunomodulatory nanoparticle treatment, if further proven in preclinical trials and human trials, would not undo damage from the initial injury to the brain. But it could help prevent the body from setting off a cascade of immune and inflammatory cells in reaction to the injury, which in turn can cause brain swelling and even more damage to brain tissue.
We certainly haven't gone and magically prevented that initial damage, said Jack Kessler, MD, professor of neurology at Northwestern University Feinberg School of Medicine and the senior author of the paper. What we can do is prevent the secondary damage, which is substantial.
Predicting which TBI patients will develop edema of the brain isn't easy, so having a preventive treatment like the nanoparticles that could be administered upfront could be life-altering, Dr. Kessler said.
He said some patients with head injuries come into the hospital walking and talking, but then their brain swells, and they die.
According to background in the study, published January 10 online in Annals of Neurology, each year more than 2.5 million people in the US have a traumatic brain TBI and more than five million Americans live with at least one sequela of TBI.
After the primary injury, there is substantial secondary injury attributable to infiltrating immune cells, cytokine release, reactive oxygen species, excitotoxicity, and other mechanisms, the study authors wrote. Despite many preclinical and clinical trials to limit such secondary damage, no successful therapies have emerged.
The nanoparticles tested in the mouse experiments are made of material used in biodegradable sutures. The paper specifically described the particles as highly negatively charged, 500 nm-diameter particles composed of the Food and Drug Administration (FDA)-approved biodegradable biopolymer carboxylated poly (lactic-co glycolic) acid.
The nanoparticles (IMPs), which seem like foreign invaders to the body's immune system, attract the attention of large white blood cells known as monocytes, which have been implicated in the secondary damage that occurs with TBI.
IMPs bind to the macrophage receptor with collagenous structure (MARCO) on monocytes and monocytes bound to IMPs no longer home to sites of inflammation but rather are sequestered in the spleen, where the cells die, the study authors wrote.
The mouse study involved two types of head injury. In some of the mice, the researchers performed a craniotomy to create a controlled cortical impact. Other mice received a closed head injury involving a direct blow to the head. Both types of injuries were meant to mimic what occurs in humans with TBI.
Injections of the nanoparticles were given two to three hours after the brain injury, and again at 24 hours and 48 hours post-injury. Control animals with similar brain injuries were given saline solution at the same time points.
Outcomes for the mice who received the nanoparticles were better by multiple measures, including MRI and a motor function test called the ladder rung walking test that is used in mouse experiments.
IMP administration resulted in remarkable preservation of both tissue and neurological function, in both models of head injury, the paper said. After acute treatment, there was a reduction in the number of immune cells infiltrating into the brain, mitigation of the inflammatory status of the infiltrating cells, improved electrophysiological visual function, improved long-term motor behavior, reduced edema formation as assessed by magnetic resonance imaging, and reduced lesion volumes on anatomic examination.
Dr. Kessler said that in the case of mice with an open head injury, the size of their brain lesion was 50 percent smaller in the treated animals compared with those that did not get the nanoparticles.
He said MRI showed significantly less brain swelling and less compression of the ventricles, both signs that secondary damage was minimized.
Dr. Kessler said that right now the only recourse for severe brain swelling is to do a craniotomy to relieve pressure in the skull.
He said one of the appeals of the nanoparticle treatment is that an emergency medical technician could do it in the field or the emergency room personnel could inject it.
But Dr. Kessler is also cautious about too many predications based on a pre-clinical study, saying he is fond of telling medical students that if I had a nickel for every mouse we cured, I'd be a rich man.
Sripadh Sharma, PhD, an MD-PhD student at Northwestern and the study's first author, said the nanoparticle therapy needs to be tested further in animal models before it could go into human testing. The researchers also want to learn more about how the nanoparticles bring about a reduced immune response in the body.
Dr. Sharma noted that while immune responses are a good thing in the face of injury or infection, sometimes nature doesn't always get it right, so too much of a good thing is a bad thing. And that can be the case with TBI.
He said it has been shown by another collaborator on the study, Stephen Miller, PhD, that when the scavenger receptors on the monocytes detect the light negative charge of the nanoparticles, the monocytes engulf and bind to the particles and apoptose in the spleen instead of going to the site of injury.
More studies need to be done to optimize what dose and what time these particles need to be given following a head injury, said Dr. Sharma.
Similar nanoparticle therapy is being tested for other medical conditions, including celiac disease and myocardial infarction, Dr. Kessler said.
Michael J. Schneck, MD, FAAN, professor of neurology (and neurosurgery) at Loyola University Chicago, said the study was well-designed and thorough, using two different head injury models and multiple outcome measures, including brain imaging, functional testing, and brain tissue analysis. Dr. Schneck said the paper made him wonder whether a similar approach using immune-modulating nanoparticles could reduce inflammatory-related damage following stroke and spinal cord injury.
Dr. Schneck said the concept of trying to dampen the immune response after TBI to prevent edema is not new, but the Northwestern researchers took the idea in a new direction. The nanoparticle therapy is particularly intriguing, he said, because it is fairly simple and involves the use of a material that is already approved by the US FDA, which could mean that it would take less time to move the therapy from the laboratory into clinical trials.
This is a very elegant study with interesting translational potential, he said. But it is a mouse model and its application to (human) TBI and other forms of central nervous system injury remains to be validated.
Jiangbing Zhou, PhD, associate professor of neurosurgery and biomedical engineering at Yale University, said that as someone who does research in the field of nanomedicine, he was surprised by the study's findings and wants to understand how this simple formulation particle could achieve this marked efficacy.
The study looks very exciting, but I want to know more about the mechanism, said Dr. Zhou, whose research focuses on developing translational nanomedicine, gene therapy, and stem cell therapy for neurological disorders including TBI.
He had these and other questions about the study: Why do the particles interact specifically with the inflammatory monocytes but not the others? How do the particles, which are made of safe biomaterials, efficiently kill the inflammatory monocytes in the spleen? What is happening and why?
Javier Crdenas, MD, director of the Barrow Concussion and Brain Injury Center at the Barrow Neurological Institute, said the study on the immune-modulating nanoparticle therapy for TBI was very promising, though he stressed that he is always cautiously optimistic when he sees a mouse study.
It is definitely a novel approach to addressing the secondary sequelae of brain injury and they might have something that minimizes that and hopefully improves outcomes, Dr. Crdenas said.
He said the study also raises some questions, including how the immune-modulating approach would fare in patients who have multiple injuries, not just to the head.
Dr. Crdenas said brain injuries often do not happen in isolation, with patients also having broken bones, lacerations, and other organ damage.
We don't know how this (nanoparticle treatment) would affect other organs, other immune responses elsewhere in the body, he said.
Dr. Crdenas said the field of TBI research has been disappointed before by studies of new therapies that looked promising in animal models and clinical testing but ultimately failed. He noted, for instance, that progesterone and hypothermia did not turn out to be good at preventing brain swelling.
We will wait and see, he said of the nanoparticles.
Drs. Sharma, Schneck, Zhou, and Crdenas had no disclosures.
Excerpt from:
Nanoparticle Therapy Might Help Reduce Brain Swelling in... : Neurology Today - LWW Journals
The latest report on Global Nanomedicine Market now available at Report Ocean, explains the contemporary and upcoming trends besides details associated with the regional landscape of the nanomedicine market that includes several regions. The report further emphasizes intricate details regarding the demand and supply analysis, contributions by leading industry players and market share growth of the nanomedicine market industry. Comprehensive secondary research was done to collect information on the market and its parent and ancillary markets. Further, primary research was performed to validate the assumptions and findings obtained from secondary research with key opinion leaders (KOL) and industry experts.
The report is a universal account of the major insights related to the geographical landscape of this business as well as the companies that have a reputable status in the nanomedicine market.
Request Free Sample Report athttps://www.reportocean.com/industry-verticals/sample-request?report_id=IR192
In this report, we analyze the nanomedicine market industry from two aspects.
1. Production In terms of its production, we analyze the production, revenue, gross margin of its main manufacturers and the unit price that they offer in different regions from 2014 to 2019.
2. Consumption In terms of consumption, we analyze the consumption volume, consumption value, sale price, import and export in different regions from 2014 to 2019.
We also make a prediction of its production and consumption in coming 2020-2026.
At the same time, we classify different nanomedicine market based on their definitions. Upstream raw materials, equipment and downstream consumers analysis is also carried out. It also focuses on market influencing factors, competitive landscape, data, trends, information, and exclusive vital statistics of the market.
The market study focuses on various key parameters that include:
Market Segmentation
Regional Segmentation
In-Depth study of Market Determinants
360-Degree Economic Analysis
Regulatory Analysis
Company Profiling and others
Competitive Landscape:
The competitive analysis of major market players is another notable feature of the nanomedicine market industry report; it identifies direct or indirect competitors in the market. The report offers company profile of market players alongside product picture and its specifications, nanomedicine market industry market plans, and technology adopted by them, future development plans. In addition, strength and weaknesses analysis of nanomedicine market industry competitive firms gives competitive advantages so that the efficiency and the productivity of companies are improved.
Market Segmentation:
The segmentation is used to decide the target market into smaller sections or segments like product type, application, and geographical regions to optimize marketing strategies, advertising technique and global as well as regional sales efforts of nanomedicine market. The common characters are also being considered for segmentation such as global market share, common interests, worldwide demand and supply of Access Control devices. Moreover, the report compares the production value and growth rate of Global Nanomedicine Market across different geographies.
This report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
The research methodology adopted by analysts to study the market include inputs derived from industry professionals across the value chain and various other secondary research methods, along with primary research as a major tool for market study.
Some of the Major Highlights of TOC covers:
Executive Summary
Global Nanomedicine Market Insights
Global Nanomedicine Market forecast by different Segments and Regions
Manufacturing Cost Structure Analysis
Development and Manufacturing Plants Analysis of Global Nanomedicine Market
Key Figures of Major Manufacturers
Why to purchase this report:
The report would provide an in-depth analysis on the current and future market trends
Analysis on global, regional and country level markets
Key strategic initiatives taken by major players operating in the market along with ranking analysis for the key players
Analysis based on historical information along with the current trends to estimate the future of the market
Analysis of the impact of constantly changing global market scenarios
3 months analyst support along with the Market Estimate sheet in excels.
For more information and discount on this report, ask your query at:https://www.reportocean.com/industry-verticals/sample-request?report_id=IR192
Note: The report historic years and forecast period can be customized on the request. Moreover, the scope of a published report can be modified as per the requirement, specific geography or country-based analysis can be provided as a part of customization
Contact: +1 888 212 3539 (US) +91-9997112116 (Outside US)Contact Person:TomEmail:[emailprotected]
Originally posted here:
Global Nanomedicine Market Outlook, Strategies, Manufacturers, Countries, Type and Application, Global Forecast To 2026 - Stop Smoking Lounge
The Nanomedicine research report is a valuable source of data for business strategists. It provides the Nanomedicine overview with growth analysis and historical and futuristic cost revenue demand and supply data. The research analysis provides an elaborative description of the value chain and distributor analysis.
Request Sample Copy of This Report: @https://99marketresearch.com/global-nanomedicine-market-size-status-and-forecast-2019-2025/102924/#Free-Sample-Report
The Nanomedicine market study provides comprehensive data that enhance the understanding, scope and application of this report.
The report provides a basic overview of the industry including definitions and classifications. The Nanomedicine analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.
Prominent players of Nanomedicine market:
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc):
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.
This report studies the Nanomedicine status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyses the top players in global market, and splits the Nanomedicine By product type and applications/end industries.
Read Detailed Index of full Research Study at @ https://99marketresearch.com/global-nanomedicine-market-size-status-and-forecast-2019-2025/102924/
To comprehend 2018-2026 Nanomedicine dynamics in the world mainly, the worldwide 2018-2026 Nanomedicine is analyzed across major global regions. Nanomedicine Also provides customized specific regional and country-level reports for the following areas.
North America: United States, Canada, and Mexico.
South & Central America: Argentina, Chile, and Brazil.
Middle East & Africa: Saudi Arabia, UAE, etc
The study objectives of this report are:
To study and forecast the market size of Nanomedicine
To analyze the global key players, SWOT analysis, value and global market share for top players.
To define, describe and forecast the market by type, end-use and region.
To analyses and compare the market status and forecast among global major regions.
To analyses the global key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting market growth.
TOC-
Check here for the discount@https://99marketresearch.com/global-nanomedicine-market-size-status-and-forecast-2019-2025/102924/#Buying-Enquiry
Customization of the Report:This report can be customized to meet the clients requirements. Please connect with our sales team (sales@99marketresearch.com), who will ensure that you get a report that suits your needs.
See original here:
Nanomedicine Market 2019 Industry Outlook, Comprehensive Insights, Growth and Forecast 2025 - Med News Ledger
Yulan Weng, 1 Jiulong Li, 1 Xingcheng Ding, 2 Binqiang Wang, 1 Shang Dai, 1 Yulong Zhou, 3 Renjiang Pang, 1 Ye Zhao, 1 Hong Xu, 1 Bing Tian, 1, 3 Yuejin Hua 1
1MOE Key Laboratory of Biosystems Homeostasis & Protection, Zhejiang University, Hangzhou, Peoples Republic of China; 2Zhejiang Runtu Chemical Research Institute, Shaoxing, Peoples Republic of China; 3Key Laboratory for Green Processing of Chemical Engineering of Xinjiang Bingtuan, School of Chemistry and Chemical Engineering, Shihezi University, Shihezi, Xinjiang, Peoples Republic of China
Correspondence: Bing TianZhejiang University Zijingang Campus West Part, A403 Biophysics Building, 866 Yuhangtang Road, Hangzhou 310058, Peoples Republic of ChinaTel/Fax +86-571-86971215Email tianbing@zju.edu.cn
Background: Biodegradation of toxic organic dye using nanomaterial-based microbial biocatalyst is an ecofriendly and promising technique.Materials and Methods: Here, we have investigated the novel properties of functionalized Au-Ag bimetallic nanoparticles using extremophilic Deinococcus radiodurans proteins (Drp-Au-AgNPs) and their degradation efficiency on the toxic triphenylmethane dye malachite green (MG).Results and Discussion: The prepared Drp-Au-AgNPs with an average particle size of 149.8 nm were capped by proteins through groups including hydroxyl and amide. Drp-Au-AgNPs demonstrated greater degradation ability (83.68%) of MG than D. radiodurans cells and monometallic AuNPs. The major degradation product was identified as 4-(dimethylamino) benzophenone, which is less toxic than MG. The degradation of MG was mainly attributed to the capping proteins on Drp-Au-AgNPs. The bimetallic NPs could be reused and maintained MG degradation ability (> 64%) after 2 cycles.Conclusion: These results suggest that the easilyprepared Drp-Au-AgNPs have potential applications as novel nanomedicine for MG detoxification, and nanomaterial for biotreatment of a toxic polyphenyl dye-containing wastewater.
Keywords: bimetallic nanoparticles, Deinococcus radiodurans, biodegradation, toxic triphenylmethane dye, malachite green, detoxification
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.
View original post here:
Functionalized Gold and Silver Bimetallic Nanoparticles Using Deinococ | IJN - Dove Medical Press
Yuri Svidinenko Nanomedicine Medical Animation including Oncology
Yuri is a noted medical illustrator who specializes in NanoMedicine, and Oncology, and speaks about the way he visualizes, and creates his excellent animated illustrations of Nanomedince and ...
By: John Bennett
Continue reading here:
Yuri Svidinenko Nanomedicine Medical Animation including Oncology - Video
MarketandResearch.bizhas recently announced the addition of new research report to its repository named,GlobalNanomedicine Market Research 2019 by Manufacturers, Regions, Countries, Types and Applications, Forecast to 2024. It provides a clear understanding of the market dynamics by studying the historical data and analyzing the current market situation. It aims to chalk the route of the market for the coming few years. It gives a comprehensive synopsis of the market picture including market overview, introduction, classification, market dynamics,and market size.
DOWNLOAD FREE SAMPLE REPORT:https://marketandresearch.biz/sample-request/85199
TheNanomedicinemarket research report includes a separate section which specifies key players profiles allowing understanding the pricing structure, cost,Nanomedicinecompany basic information, their contact details,and product category.
Main leading players in theNanomedicineMarket Are:, Combimatrix, Ablynx, Abraxis Bioscience, Celgene, Mallinckrodt, Arrowhead Research, GE Healthcare, Merck, Pfizer, Nanosphere, Epeius Biotechnologies, Cytimmune Sciences, Nanospectra Biosciences, ,
GlobalNanomedicinehas witnessed gradual growth in recent years and is expected to witness steady growth in the forecast period.In this report, theNanomedicinemarket is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2024, growing at a CAGR of XX% between 2019 and 2024.
TheNanomedicinereport contains brief information on these trends that can help the businesses operating in the industry to know constituents of the market and strategize for their business expansion accordingly. Moreover, various rudimentary aspects of theNanomedicinemarket such as market size, industry share, growth, key segments, and CAGR are also added in the report. The next section of the report serves detailed overview ofNanomedicineproduct specification, product type, product scope, and production analysis with key factors such as capacity, production, revenue, price and gross margin.
The notable feature of this report is that it presents an all-enclosing view of theNanomedicinemarket based on its segmentation, with respect to types, application, end-users, products, and geography.
The report executes the great study of capacity, production, revenue, price, gross margin, technology, demand-supply, consumption, import, export, market drivers and opportunities.It also discusseslimitations, risks, and challenges which will decide the standing future of the market all over the world.
The Study Report Provides In-depth Analysis On:
ACCESS FULL REPORT:https://marketandresearch.biz/report/85199/global-nanomedicine-industry-market-research-2019-by-manufacturers-regions-countries-types-and-applications-forecast-to-2024
Furthermore, manufacturing cost structure combines analysis of key raw materials, their price trends along with labor cost and manufacturing expenses. For market chain analysis, the report covers upstream raw materials, equipment, downstream buyers, marketing channels, and market development trend which more deeply include important information on key distributors/traders, major raw materials suppliers and contact information, major manufacturing equipment suppliers, major suppliers, and key consumers.
The report profiles SWOT analysis and market strategies of the key players. Any individual or organization interested in the report can greatly benefit from it. The market research data added in the study is the result of extensive primary and secondary research activities, surveys, personal interviews, and inputs from industry expert.
Go here to read the rest:
Global Nanomedicine Market 2019 Industry Outlook, Comprehensive Insights, Growth and Forecast 2024 - The Chicago Sentinel
An automated method of conducting materials science research can increase productivity by 384 times when compared to a human, according to researchers.
The robot-plus-software system also makes it easier for people who are not expert researchers or scientists to create new materials.
A Rutgers-led team of engineers has developed an automated way to produce polymers, making it much easier to create advanced materials aimed at improving human health.
The team says this innovation is a critical step in pushing the limits for researchers who want to explore large libraries of polymers, including plastics and fibers, for chemical and biological applications such as drugs and regenerative medicine through tissue engineering.
While a human researcher may be able to make a few polymers a day, the new automated system featuring custom software and a liquid-handling robot can create up to 384 different polymers at once, a huge increase over current methods.
Synthetic polymers are widely used in advanced materials with special properties, and their continued development is crucial to new technologies, according to a study in the journal Advanced Intelligent Systems. Such technologies include diagnostics, medical devices, electronics, sensors, robots and lighting.
Senior author Adam J. Gormley, an assistant professor in the Department of Biomedical Engineering in the School of Engineering at Rutgers UniversityNew Brunswick, says: Typically, researchers synthesize polymers in highly controlled environments, limiting the development of large libraries of complex materials.
By automating polymer synthesis and using a robotic platform, it is now possible to rapidly create a multitude of unique materials.
Robotics has automated many ways to make materials as well as discover and develop drugs.
But synthesizing polymers remains challenging because most chemical reactions are extremely sensitive to oxygen and cant be done without removing it during production.
The Gormley labs open-air robotics platform carries out polymer synthesis reactions that tolerate oxygen.
The group developed custom software that allows a liquid handling robot to interpret polymer designs made on a computer and carry out every step of the chemical reaction.
One benefit is that the new automated system makes it easier for non-experts to create polymers.
The lead author is Matthew Tamasi, a Rutgers doctoral student. Co-authors include doctoral student Shashank Kosuri and undergraduate student Jason DiStefano.
A researcher at the Australian Centre for Nanomedicine and Centre for Advanced Macromolecular Design contributed to the study, which was funded by the New Jersey Health Foundation.
You might also like
While giving a talk at a conference in Australia in the mid-2000s, IBM Research's lead scientist for the advanced organic materials group, James Hedrick, had an encounter that would make him rethink his career. At one point, Hedrick--who holds more than 100patents--took a question from a woman in the audience. It wasn't what he was expecting. "Why are you wasting your time with all this electronics stuff?" asked Dr. Yi Yan Yang, who works at the Institute of Bioengineering and Nanotechnology in Singapore. "You need to work with me." That evening, Yang filled Hedrick in on how she was using high-tech nanomaterials for medical purposes. "She was absolutely right," Hedrick recalls. "I was wasting time doing just semiconductors."
The result was IBM's unusual nanomedicine program, an ongoing collaboration between Hedrick's team at the Almaden, Californiabased IBM Research and Yang's group of researchers in Singapore. The project is tackling a range of ambitious projects: creating better antimicrobial and antifungal agents, new methods of drug delivery, and novel ways of combating such diseases as HIV/AIDS and tuberculosis. It may seem strange that computer-hardware giant IBM is pouring resources into experimental nanomedicine, but it's part of a larger trend within the company. "There is a huge group of IBMers who think we should be using our intellectual know-how to address global problems," says Spike Narayan, director of IBM Research's science and technology group. "As we've pushed the boundaries and engaged with other disciplines, we've found that some of our capabilities in materials and nanotechnology are very relevant in addressing challenges related to water, energy, the environment, and health care. That's the motivation."
Although it has yet to yield a commercial product (Narayan says several joint ventures are in the works), the program also makes sense from a business perspective. Even as the price of computing power keeps falling for consumers, R&D and manufacturing costs are steadily increasing for semiconductor producers. That's squeezing profits: Between 2000 and 2012, IBM's hardware business went from contributing 35% of the company's pretax income to just 14%. Perhaps that's why in February 2014, Big Blue reportedly hired Goldman Sachs to explore a potential sale of its semiconductor operation. New areas such as nanomedicine could offer a way for IBM to continue profiting from its cutting-edge research in nanomaterials even if it does get out of semiconductors. "Now we have an ITcentric focus," says Narayan, "but there's no reason we couldn't be more materials-focused, providing enabling technology for other companies."
The nanomedicine group's first big breakthrough was the creation of polymer-based nanoparticles that can target and kill MRSA, a potentially deadly drug-resistant bacterium. The nanoparticles engineered by the IBMSingapore team--dubbed "ninja particles"--use electrostatic attraction to target infected cells. Because the polymers used to create ninja particles are biodegradable, they pass out of the body once they've done their job. While the particles haven't yet been submitted for FDA approval, IBM is working with pharmaceutical, consumer-products, and medical-device companies to explore applications.
In the past year, the pace of innovation has accelerated. The Hedrick-Yang group published a paper in December that describes a method for breaking down PET--the stuff plastic bottles are made of--and reconstructing it into a nanofiber that can kill fungal infections on contact. In the lab, these nanofibers were more effective in fewer doses than conventional antifungal drugs, in addition to being nontoxic and biodegradable. Since the polymers used in both chip manufacture and nanomedicine are generally derived from petroleum, the ability to instead start from recycled material could reduce industrial consumption of oil and gas while providing a new use for plastic waste.
Hedrick and his partners have also made headway in drug delivery, coaxing nanoparticles to self-assemble into a gel-like material that can encapsulate molecules of a drug and release them at a particular location in the body over an extended period of time. When the Singapore team encapsulated the breast cancer drug Herceptin into the hydrogel and injected it into animals, their tumors shrank more than 75%, and the drug remained active and effective in the bloodstream for a month after a single injection. Tumors in animals given a regular IV injection of the drug didn't shrink at all, according to results published in November 2013.
Potential medical and consumer applications for materials coming out of the nanomedicine program are practically limitless: they could be injected; applied as a topical gel to treat wounds and infections; included in products such as soap, hand sanitizer, and shampoo; or applied as a germ-fighting coating on everything from medical devices to cutting boards and toothbrushes. Before they can be commercialized, all of these products will require approval by either the EPA or FDA, so rather than bring products to market on its own, IBM will aim to collaborate with partners that have more regulatory and manufacturing expertise. "Increasingly, in these nontraditional, interdisciplinary spaces, no one has all the capabilities," says Narayan. "As we jointly develop [intellectual property], there will be all kinds of royalty and other revenue streams coming out." The first product to make it out of the lab will most likely be an antimicrobial material to clean surfaces in hospitals.
For Hedrick, pivoting from his comfort zone in silicon hardware has been a learning process. "When I first started this, we went to some major pharma companies, and I got my backside handed to me pretty quick," he says. "Now I feel very comfortable going into a room with scientists and executives and rattling off proteins and numbers and names. A lot of the time [when he's not in meetings], though--I kid you not--I have Wikipedia open on my phone."
Inspired in part by the recent launch of an IBM Research lab in Africa, Hedrick is excited about deploying nanomaterials to fight illnesses that disproportionately afflict the region, including tuberculosis, dengue fever, and HIV. He also hopes to look at ways to use nanocontainers to deliver drugs across the blood-brain barrier--a major challenge in treating conditions such as Alzheimer's and Parkinson's. "Even three years ago, I would have been surprised by what we've been able to accomplish so far," he says. "IBM Research has given us significant latitude and freedom. Because they've always kept the lights on, we're able to address these grand challenges in a unique way."
Originally posted here: